Human+

What you're buying

Human+ has rebuilt itself around one condition. Where it used to sell a flat monthly membership covering weight loss, hair, sexual wellness, mental health and labs, the site we read in August 2026 is a single-page pitch headed "GLP-1 CARE BUILT AROUND YOUR LIVER", aimed squarely at people with fatty liver disease. The weight-loss framing is gone; the argument is that a GLP-1 clears fat out of the liver and the liver heals itself from there.

The medicine underneath is familiar. The options block says "Two GLP-1s. Three ways to take them" and lists compounded semaglutide by injection, compounded tirzepatide by injection, and tirzepatide taken orally, with shipping included, no membership fees, no dose upcharges and no insurance. The footer then lists four treatments rather than three, adding oral semaglutide, so even the product count contradicts itself between the middle of the page and the bottom of it.

The clinical claims are handled better than the commercial ones. Human+ walks through four stages of liver disease — steatosis, NASH, fibrosis and cirrhosis — with an honest note that cirrhosis is beyond what the program treats and that it will say so and point you to a specialist. Medications are filled by a network of licensed US 503A and 503B compounding pharmacies and reviewed by US-licensed clinicians, though no individual pharmacy, clinician or medical director is named. The entity in the footer is HUMAN+ HEALTH, INC., San Francisco and New York.

What it costs (and how it's billed)

There is no price on this website. Not a figure, not a range, not a starting-at number — the words "One flat price, everything included" appear twice, and the flat price itself appears nowhere. Neither does a billing cycle, a plan length, a cancellation rule, a refund policy or a shipping charge.

That is not a case of pricing sitting one click deep, either, because there is nowhere to click. The footer carries a navigation list with entries for Pricing, How it works, The liver science, Reviews, About, Clinicians, Contact, Terms, Privacy, Telehealth consent and HIPAA, and none of them goes anywhere: every one of them is an anchor to the top of the same page. The only real outbound link on the site is the intake button, and when we followed it the page returned "Form Not Found — Teleform not found or inactive".

So the honest description of what Human+ costs today is that we could not find out, and neither can a reader. What we can say is what the page promises the price will contain when it appears: the medication, shipping, provider review, and no membership fee or dose upcharge — which, if true, would be a meaningful change from the membership-plus-wholesale-cost model this company used to run.

Who can order

Human+ claims all 50 states. The footer's summary line reads "GLP-1 care built around your liver. Telehealth in all 50 states", and a partial state list is visible mid-page — Arkansas, California, Colorado, Connecticut, Delaware, Florida and so on — inside a component that appears to be a state picker for the intake.

The clinical gate is described in prose rather than criteria. There is no body-mass-index threshold on the page, no contraindication list, no minimum age stated, and no indication of which states need a live video visit. The one exclusion Human+ does state is a clinical one and it is to the company's credit: if your disease has reached cirrhosis, it says the program is not for you.

How the intake works

In theory: a three-minute liver quiz, then a conversation with a licensed clinician, then medicine. The page describes it as "From intake to medicine, in three steps" and repeats the three-minute promise in four separate call-to-action buttons.

In practice, on the day we read it, none of those buttons reached a working form. Every quiz button on the page resolves to the same intake address, and that address returns a not-found message from the form host rather than a questionnaire. We could not test the review speed, the clinician contact, the shipping time or the support channel, because there is no way onto the platform from the public site and no phone number or email address published on it.

What we'd want changed

Fix the intake, then publish a price. A site whose only working function is a dead form is not selling anything, and a company that says "One flat price, everything included" twice on one page and never prints the price is asking for trust it has not earned. Every one of the eleven footer links needs to lead to the page it names, starting with Pricing, Terms and Clinicians.

Then read the page back before publishing it. The browser tab on this site is titled "Human+ — mobile homepage mockup", the safety block at the bottom contains the editorial note "Prevalence figure to be verified" sitting in the middle of live regulatory copy, and the product count differs between the middle of the page and the footer. Those are three separate signs that what is live is a draft, on a site that asks people with liver disease to hand over their medical history.

Bottom line

The idea here is a good one and the clinical writing is better than most of this category — staging liver disease honestly, saying out loud where the program stops, offering an oral route alongside injections. None of that is buyable today. There is no price, no terms, no named pharmacy or clinician, no working link except one that fails, and a page title that describes itself as a mockup. Until the form works and the price is printed, there is nothing here for a reader to act on, and we would not enter a medical history into it.